Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Clinical ink secures a strategic investment from Ardan Equity and GI Partners to accelerate its growth. The new equity aims to enhance Clinical ink's global platform and innovate solutions in clinical trials.
Round Type
Corporate Round
Winston-SalemOtherInvestors
Description
Clinical ink, a clinical trial technology company, announced new investments from Ardan Equity and GI Partners to support its growth. These investments will enable Clinical ink to expand its global footprint and enhance its technological solutions. The collaboration aims to further scale Clinical ink's platform while pursuing new opportunities in clinical research. With the partnership's complementary expertise, Clinical ink seeks to meet the evolving needs of the industry.
Fundz sees it the moment Clinical Ink, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Clinical Ink, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.